No link between Merck's Gardasil and MS risk, study shows

Merck's Gardasil HPV vaccine--FierceBiotech file photo
Merck's Gardasil

Merck ($MRK) and partner Sanofi ($SNY) can breathe easy: According to a new study, their blockbuster HPV shot Gardasil isn't linked to an increased risk of multiple sclerosis. In a study published Tuesday in JAMA, researchers found that in a population of 3.9 million girls and women, those vaccinated with Gardasil had lower rates of MS and similar CNS diseases. Story